Dr. Dipali P. Nemade, MD

Dr. Nemade practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Nemade's NPI, 1679008387, was assigned on May 1, 2017. Dr. Nemade graduated from Marshall University Joan C. Edwards School of Medicine in 2009. Dr. Nemade holds Florida license ME155396.

Dr. Nemade's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Nemade's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Nemade is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Nemade to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nemade practices, 7 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Nemade's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Nemade is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Nemade's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists epilepsy, head injury, migraine and chronic headache, neuropathy and sleep apnea among the conditions Dr. Nemade treats.

CMS data shows 256 Medicare services from Dr. Nemade across 6 procedure codes in 2024, for 203 Medicare patients. Medicare paid $25,094 for them.

CMS counts 203 Medicare patients who saw Dr. Nemade in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nemade's median patient age at 69, with 48% women.

In 2024, Dr. Nemade wrote 531 Medicare Part D claims for 81 patients. 71% of them were for generic drugs. CMS names the drug for 452 of them, across 15 drugs with 11 or more claims each, at $215,815 in total drug cost. In 2023, CMS named 249 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Nemade for performance year 2024, reported as part of a group. Dr. Nemade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Nemade, published from 2019 to 2021. 2020 was the busiest year, with 2. Dr. Nemade has published most often in Cureus. Dr. Nemade's most frequent co-authors are Vikram Shivkumar, MD, Ashar Mazhar Farooqi, MD and Paul B. Ferguson, MD.

CMS Open Payments shows 305 general payments to Dr. Nemade from 38 drug and device companies from 2020 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. UCB, Inc. paid the most, $32,005.

Dr. Nemade graduated from Marshall University Joan C. Edwards School of Medicine in 2009.

Dr. Nemade is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.